Biogen Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BIIB Nasdaq 2834 www.biogen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biogen Inc.

Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know - May 12th, 2025 6:11 pm
How To Invest: Using Shorter-Term Moving Averages To Trade Stocks - May 12th, 2025 12:00 pm
Q1 2025 Royalty Pharma PLC Earnings Call - May 9th, 2025 3:51 am
Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT) - May 8th, 2025 3:31 am
Biogen (NasdaqGS:BIIB) Selects Multiple Co-Lead Underwriters for US$1 Billion Fixed-Income Offering - May 7th, 2025 5:32 pm
2 Mid-Cap Stocks to Keep an Eye On and 1 to Ignore - May 6th, 2025 4:32 am
4 Stocks to Buy for a Potential “Summer Panic” - May 4th, 2025 4:00 pm
Biogen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - May 3rd, 2025 12:33 pm
Biogen Emerging as 'Leaner, Less Risky' Company, RBC Says - May 2nd, 2025 3:58 pm
Biogen Inc (BIIB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst MS Franchise ... - May 2nd, 2025 7:05 am
Q1 2025 Biogen Inc Earnings Call - May 2nd, 2025 4:43 am
Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - May 1st, 2025 6:07 pm
Biogen (NasdaqGS:BIIB) Reports Q1 Revenue Growth Despite Decline in Net Income - May 1st, 2025 5:35 pm
BIIB's Q1 Earnings Miss, Revenues Top Mark, 2025 EPS Guidance Cut - May 1st, 2025 4:44 pm
Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - May 1st, 2025 1:30 pm
Is Biogen At The 'Start Of A Turnaround' On Its Quarterly Beat? - May 1st, 2025 1:28 pm
Biogen (NASDAQ:BIIB) Beats Q1 Sales Targets - May 1st, 2025 1:22 pm
Biogen Inc. (BIIB) Q1 Earnings Lag Estimates - May 1st, 2025 12:05 pm
Biogen's results beat estimates on strength in rare disease drugs - May 1st, 2025 10:48 am
Biogen Inc. (NASDAQ:BIIB) is largely controlled by institutional shareholders who own 90% of the company - Apr 30th, 2025 5:31 pm